About Eligo Bioscience
Eligo Bioscience is the world leader in microbiome in-vivo gene editing and is advancing a highly differentiated pipeline of precision medicines to address unmet medical needs in immunoinflammation, oncology, and infectious diseases driven by the expression of deleterious bacterial genes. Eligo was founded by Luciano Marraffini (Professor at The Rockefeller University and cofounder of Intellia Therapeutics, Timothy Lu (Professor at MIT, and CEO at Senti Biosciences), Dr. David Bikard (Professor at Institut Pasteur) and Xavier Duportet (MIT TR35, Young Global Leader, and Termeer Fellow). Eligo was named a Technology Pioneer by the World Economic Forum and received venture capital funding from Sanofi Ventures, Khosla Ventures, BPI France, and Seventure Partners.
- Founding: 2014
- Focus : Manufacturer
- Employees: 11-50
- Industry : Biotechnology
Advertisement
Here you will find Eligo Bioscience
Last viewed contents
Heqet Therapeutics - Torino, Italy
Merck Life Science KGaA - Darmstadt, Germany
Colorectal cancer screening via smartphone? - App-based early detection is as accurate as laboratory tests and could motivate more people to undergo screening
Mobile One Health laboratory for diagnosing highly pathogenic pathogens
Berlin-based blood analysis innovator aescolab secures new capital - Start-up uses AI for personalized health analyses
Human–AI collectives make the most accurate medical diagnoses - Study highlights the potential for greater patient safety and more equitable healthcare
Ear wax as a possible screening medium for Parkinson’s disease
Making fibrosis visible – before it’s too late - With planned ETH spin-off to market maturity
New nanosensors make diagnostic procedures more sensitive - The nanosensors can be used to track reactions with invisible light, saving materials and time
Cyber Valley grants 500K to CELL’n’ROLL via 2023 Innovation Fellowship Program - Cyber Valley Community is advancing diagnostics for the future: Its goal is to create an innovative spin-off from the project after the funding term has ended
Blood diagnostics modelled on leeches - For all those who are afraid of needles: New device for taking blood samples uses microneedles and a suction cup instead of a large needle
